New international research collaboration explores blood-based biomarker testing to identify cancer patients that could potentially respond to immunotherapy 5. november 2018Alt om Cancer(link-samling), Bio-kemi, metaboliske processer og DNA(link-samling), Forebyggelse, Præventive Strategier & Immunitet, Sundheds-emner(link-samling), Videnskabelige ArtiklerIngen kommentarerJon Ch. Henningsen
